Hepatitis C News and Research

Latest Hepatitis C News and Research

Long-term morbidity and mortality of NAFLD patients with advanced fibrosis, cirrhosis

Long-term morbidity and mortality of NAFLD patients with advanced fibrosis, cirrhosis

28 Sep 2011
Liver transplantation candidates without HCC derive greater survival benefit from LDLT

Liver transplantation candidates without HCC derive greater survival benefit from LDLT

28 Sep 2011
State roundup: Consumer advocates oppose Ga. request to ease rules on insurers' profits

State roundup: Consumer advocates oppose Ga. request to ease rules on insurers' profits

22 Sep 2011
New FDA-approved antiviral drugs offer treatment hope for hepatitis C

New FDA-approved antiviral drugs offer treatment hope for hepatitis C

21 Sep 2011
Antivirals from shark cartilage compound squalamine

Antivirals from shark cartilage compound squalamine

21 Sep 2011
Financial and political commitments to improve health of women and children

Financial and political commitments to improve health of women and children

21 Sep 2011
Scientists discover how liver destroys immune T-cells

Scientists discover how liver destroys immune T-cells

20 Sep 2011
Chronic diseases could cost $47 trillion over the next 20 years: Report

Chronic diseases could cost $47 trillion over the next 20 years: Report

19 Sep 2011
NanoViricides acquires light industrial building for laboratory facilities and cGMP production

NanoViricides acquires light industrial building for laboratory facilities and cGMP production

19 Sep 2011
Inhibitex initiates INX-189 combination Phase 2 trial in HCV-infected genotype 2/3 patients

Inhibitex initiates INX-189 combination Phase 2 trial in HCV-infected genotype 2/3 patients

19 Sep 2011
Georgia reminds adults to get vaccinated

Georgia reminds adults to get vaccinated

16 Sep 2011
Teva to invest in CDI for development of novel antiviral drugs

Teva to invest in CDI for development of novel antiviral drugs

16 Sep 2011
Shorter treatment with telaprevir-based combination regimen may benefit hepatitis C patients

Shorter treatment with telaprevir-based combination regimen may benefit hepatitis C patients

16 Sep 2011
Experimental malaria vaccine shows positive results among children in small Burkina Faso study

Experimental malaria vaccine shows positive results among children in small Burkina Faso study

16 Sep 2011
VBI Vaccines completes acquisition of Epixis

VBI Vaccines completes acquisition of Epixis

15 Sep 2011
Patients with hepatitis C may benefit from 24 week telaprevir-based regimen

Patients with hepatitis C may benefit from 24 week telaprevir-based regimen

15 Sep 2011
NEJM publishes data from Vertex INCIVEK Phase 3 study on genotype 1 chronic hepatitis C

NEJM publishes data from Vertex INCIVEK Phase 3 study on genotype 1 chronic hepatitis C

15 Sep 2011
'Achilles' heels' within HCV virus

'Achilles' heels' within HCV virus

14 Sep 2011
Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

14 Sep 2011
Breakthrough opens new avenues for hep C vaccine

Breakthrough opens new avenues for hep C vaccine

12 Sep 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback